1. Home
  2. WST vs IONQ Comparison

WST vs IONQ Comparison

Compare WST & IONQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • IONQ
  • Stock Information
  • Founded
  • WST 1923
  • IONQ 2015
  • Country
  • WST United States
  • IONQ United States
  • Employees
  • WST N/A
  • IONQ N/A
  • Industry
  • WST Medical/Dental Instruments
  • IONQ Wholesale Distributors
  • Sector
  • WST Health Care
  • IONQ Industrials
  • Exchange
  • WST Nasdaq
  • IONQ Nasdaq
  • Market Cap
  • WST 20.1B
  • IONQ 20.4B
  • IPO Year
  • WST N/A
  • IONQ N/A
  • Fundamental
  • Price
  • WST $299.62
  • IONQ $60.06
  • Analyst Decision
  • WST Strong Buy
  • IONQ Strong Buy
  • Analyst Count
  • WST 8
  • IONQ 10
  • Target Price
  • WST $348.00
  • IONQ $57.50
  • AVG Volume (30 Days)
  • WST 707.3K
  • IONQ 36.1M
  • Earning Date
  • WST 10-23-2025
  • IONQ 11-05-2025
  • Dividend Yield
  • WST 0.30%
  • IONQ N/A
  • EPS Growth
  • WST 0.17
  • IONQ N/A
  • EPS
  • WST 6.75
  • IONQ N/A
  • Revenue
  • WST $3,017,900,000.00
  • IONQ $52,370,000.00
  • Revenue This Year
  • WST $6.49
  • IONQ $116.26
  • Revenue Next Year
  • WST $6.23
  • IONQ $87.38
  • P/E Ratio
  • WST $44.06
  • IONQ N/A
  • Revenue Growth
  • WST 4.92
  • IONQ 67.83
  • 52 Week Low
  • WST $187.43
  • IONQ $14.15
  • 52 Week High
  • WST $352.33
  • IONQ $84.64
  • Technical
  • Relative Strength Index (RSI)
  • WST 72.87
  • IONQ 45.57
  • Support Level
  • WST $260.12
  • IONQ $52.27
  • Resistance Level
  • WST $322.34
  • IONQ $84.64
  • Average True Range (ATR)
  • WST 7.39
  • IONQ 6.72
  • MACD
  • WST 3.28
  • IONQ -2.72
  • Stochastic Oscillator
  • WST 64.97
  • IONQ 24.08

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About IONQ IonQ Inc.

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

Share on Social Networks: